Search Results 141-150 of 11141 for fsa eligible items 2026

  1. Early Feasibility Study Of HyperQureTM RDN System, Laparoscopic Renal Denervation Therapy, In Patients With Resistant Hypertension - Mayo Clinic

    Subjects are eligible to participate if all of the following criteria are met: ... © 1998-2026 Mayo Foundation for Medical Education and Research (MFMER). All ...

  2. A Clinical Trial To Assess The Safety Of A Novel Scaffold Biomaterial

    Participation eligibility. Participant eligibility ... Mayo Clinic does not endorse any of the third party products ... © 1998-2026 Mayo Foundation for Medical ...

  3. Medical Research & Education - Mayo Clinic News Network

    May 27, 2026. How 60 years of health data helped shape modern medicine ... May 19, 2026. Unlocking the brain: New research is changing how tumors are ...

  4. Pregnancy and COVID-19: What are the risks? - Mayo Clinic

    Preventing COVID-19 during pregnancy and breastfeeding. The 2026-2027 COVID-19 vaccines available in the United States include Moderna, Pfizer-BioNTech and ...

  5. Health Topics - Mayo Clinic News Network

    Kelsey Riegler. June 12, 2026. Endometriosis and fibroids: Expert explains ... Sharon Theimer. June 11, 2026. Mayo Clinic Q&A: Scoliosis in adults featured ...

  6. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    ... eligible for participation in Cohort A Induction Study: ... Mayo Clinic does not endorse any of the third party products ... © 1998-2026 Mayo Foundation for Medical ...

  7. A Study To Determine The Effectiveness And Safety Of Benralizumab For Patients With Severe Nasal Polyposis - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. Health Topics - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. June 24, 2026. Mayo Clinic Platform_Accelerate selects new cohort of healthcare technology startups featured ...

  9. Study To Evaluate The Safety, Pharmacokinetics And Clinical Benefit Of FLU-IGIV In Hospitalized Patients With Serious Influenza A Infection

    Participation eligibility. Participant eligibility ... Mayo Clinic does not endorse any of the third party products ... © 1998-2026 Mayo Foundation for Medical ...

  10. Phase 3 Study Of T-DXd And Rilvegostomig Versus SoC In Advanced HER2-expressing Biliary Tract Cancer - Mayo Clinic

    Eligibility last updated 01/12/2026. Questions regarding updates should be directed to the study team contact. Participating Mayo Clinic locations. Study ...